SLSN · Solesence, Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q2 FY26 earnings call · Aug 11, 2026TL;DR. Solésence reported Q2 2026 revenue of $15.3 million (down from $20.4 million) and a net loss of $158,000, while disclosing a historical inventory costing restatement and guiding to a record second half of approximately $35 million and full-year revenue growth versus 2025, supported by $64.9 million in shipped and on-hand orders.
- + Guides to record second-half revenue of approximately $35 million, the strongest in company history
- + Guides to full-year 2026 revenue growth versus 2025 with shipped and on-hand orders of $64.9 million, up from $60.0 million
- + Q2 2026 gross margin of 31% achieved on 25% lower revenue, cited as evidence of labor efficiency gains
- − Q2 2026 revenue declined to $15.3 million from $20.4 million year-over-year
- − Company disclosed a historical inventory costing restatement requiring remediation of internal controls
- − Swung to a net loss of $158,000 in Q2 2026 from net income of $3.2 million in Q2 2025
- − Adjusted EBITDA fell to $523,000 from $3.7 million year-over-year, with one-time Refy-related charges of approximately $938,000 cited
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $222K | Six months ended June 30, 2026 | — |
| shipped and on-hand orders | 64.9M | as of August 17, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SLSN
this stock
Solesence, Inc.
|
$63.07M | -43.8% | +18.6% | — | 0.5% |
|
PG
PROCTER & GAMBLE Co
|
$366.54B | +11.2% | +3.3% | 23.8 | 1.1% |
|
UL
Unilever PLC
|
$141.53B | -0.3% | — | — | 0.2% |
|
CL
Colgate Palmolive Co
|
$75.36B | +19.6% | +1.7% | 37.4 | 3.0% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$46.35B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SLSN | -9.1% | +11.7% | -30.8% | +9.8% | -43.8% |
| SPY | -1.2% | -0.6% | +8.1% | +0.8% | +12.8% |
| vs SPY | -7.9% | +12.2% | -38.9% | +8.9% | -56.5% |